Biotechnology

Single Source Procurement steps into Pfizer’s wake, opens Ann Arbor office

Bob Engster is picking up the pieces left behind by Pfizer and making quite the nice chunk of change.The Kalamazoo resident founded Single Source Procurement in 2003 after Pfizer bought Upjohn. It was the corporation's move that left Engster looking for a new job, so he created his own. He was Single Source Procurement's only employee those first few years, helping small companies and start-ups save money whenever they bought, stored or fixed biotech and life sciences equipment. Today he oversees a staff of six in Kalamazoo and plans to open an Ann Arbor office with three employees later this month. It's looking for instrument repair people right now.Engster's company has discovered that there is a demand for his services in places where Pfizer has pulled up stakes and left a wake of start-ups, such as Ann Arbor, Holland and Kalamazoo."We kind of follow Pfizer," Engster says. "We have a lot of opportunities in Michigan."Most start-ups or small companies have to pay high prices for bio-tech equipment. Single Source Procurement leverages the vendors by buying in bulk for a large number of these small firms. It also does stockroom management and helps fix these bio-tech instruments. That usually works out to about 30 percent savings for the companies and another company created in Michigan.Source: Bob Engster, CEO and founder of Single Source ProcurementWriter: Jon Zemke

Latest in Biotechnology
Compendia Bioscience lands $3 million VC, plans to create 20 new jobs

Compendia Bioscience plans to use $3 million in newly acquired venture capital to create another 20 jobs in Ann Arbor, more than doubling its current staff.Most of that $3 million, $1.75 million of it, comes from Michigan's 21st Century Jobs Fund. The rest is matching funds the bio IT firm has raised on its own.Compendia Bioscience, only 2 years old, has established itself as a leader in research-centric software development. Its products help researchers sift through mounds of biological data, enabling them to find answers to clinical questions quicker. The company counts 12 of the Top 20 cancer biopharmaceutical firms and more than 12,000 academics as customers. Compendia Bioscience's Oncomine product is now an important tool for cancer researchers in both academia and drug development companies. The company hopes to expand this platform for research on other diseases and use it to develop intellectual property. Source: Michigan Economic Development Corporation and Compendia BioscienceWriter: Jon Zemke

Local life sciences industry puts on strong showing at MichBio Expo

Michigan's life sciences industry recently flexed its muscles with the 4th-annual MichBio Expo.Five hundred bioscience professionals and dozens of exhibitors attended the event in Novi. Sixteen companies presented their products and business plans to an audience of venture capitalists and angel investors. It's things like these that makes Stephen Rapundalo, president and CEO of MichBio, think there is a direct correlation between things like the expo and local business creation. "The expo is absolutely critical for fostering business opportunities for a variety of companies," Rapundalo says. "It's also a great networking opportunity where a lot of businesses emerge." At first this year's expo didn't look like it was going to be as successful as previous ones. The economy and dour mood in business left Rapundalo and other organizers thinking it might not hit the just under 500 average. But those doubts proved to be misguided when the more than 500 attendees showed up. "There was a mad rush at the last minute," Rapundalo says. A number of local businesses and entrepreneurs received awards. John D. Schwartz, CEO of AI Medical Devices, won the first Innovator of the Year Award. Ann Arbor's Accuri Cytometers took home the Good to Great Award for making the biggest leap forward in business.A number of local students and teachers also took part in the expo's lectures and demonstrations. Next year's expo is set to take place in Kalamazoo.Source: Stephen Rapundalo, president and CEO of MichBioWriter: Jon Zemke

Ann Arbor’s Torrey Path plans to open data center

Torrey Path, the 1-year-old start-up, is off to a good start in Ann Arbor. The firm employs five full-time staffers, four people part-time and the occasional intern. It also just opened an office in California.Peter Dresslar started the firm after doing a stint as a consultant at a local pharmaceutical company. He discovered processes and designed software that can aggregate bio data easily and efficiently for research managers in the pharmaceutical and biotechnology fields.The process has turned the firm to into an almost overnight success. Torrey Path counts three of the top 10 pharmaceutical companies as clients and hopes to expand its customer base to the low teens by 2010. But before that, Dresslar expects to break the $1 million revenue mark next year."We're at a point where our solutions are at a Beta stage, which makes it much easier to sell," Dresslar says.Which, of course, means more expansion for Torrey Path. The company plans to create a data center within the next year. It's currently looking at locations in Michigan, Indiana and Ohio.Which will mean will mean another 5-15 jobs for the selected spot. Go Blue!Source: Peter Dresslar, founder and CEO of Torrey PathWriter: Jon Zemke

Chelsea’s International Discovery Sourcing Consultants grows to 9 people

In the wake of disaster, some people stare into the abyss and see doom, others see opportunity. Mark Creswell saw opportunity when Pfizer closed its Ann Arbor campus early last year."There was a tremendous amount of talent displaced," Creswell says.That led him to create International Discovery Sourcing Consultants. The Chelsea-based company focuses on helping start-up companies get off the ground, especially bio-tech and pharmaceutical companies.IDSC started with Creswell as its sole employee 18 months ago and now employs nine people. The firm hopes to add another 15-18 people within the next two years and build new office space in downtown Chelsea to house them.IDSC's growth is attributed to its increasing number of clients. It started with just a handful and now has nearly 30, including the likes of Velcura Therapeutics. Yet more are expected in the near future.Source: Mark Creswell, president and CEO of International Discovery Sourcing ConsultantsWriter: Jon Zemke

Kalamazoo’s Armune Bioscience opens research lab in Ann Arbor, hires 3

The start-up Armune Bioscience maybe headquartered in Kalamazoo, but the firm's products will come from Ann Arbor.The 3-month-old firm recently opened a research lab in the Medical Research Institute Building in Ann Arbor. The reason, it was the best and only place for it."That's where the talent was," says Eli Thomssen, president and CEO of Armune Bioscience. "The people we wanted were living there. That's where the technology was licensed."The firm is developing a diagnostic test for early detection of lung and prostate cancer using a blood sample. Thomssen points out there are no early-detection test for these diseases, leaving a void his firm hopes to fill. It hopes to eventually make this test available for breast cancer, too. To do that the five-person firm has hired three people for its Ann Arbor lab. It hopes to at least double that number within the next year.Source: Eli Thomssen, president and CEO of Armune BioscienceWriter: Jon Zemke

SoloHill expands to develop vaccine technology, hires ex-Pfizer workers

SoloHill has been around Ann Arbor for a while and likes it. So much so that the bio-tech company has hired a few Pfizer refugees and plans to hire another 4-5 people this year.

Terumo consolidates operations in Ann Arbor, plans to hire 65

Terumo Cardiovascular Systems is turning conventional wisdom on its ear, moving its operations from California to Ann Arbor and planning to hire 65 people by 2014.

Accuri Cytometers raises $13 million in venture capital, plans to double in size

Accuri Cytomers makes the products that measure cells, but the company is working on measuring its employee count. The company has gone from two to 35 people and expects to double in size within 18 months.

Video HandyLab, Inc.

If you're looking for the perfect example of a company that leverages Michigan's new innovations and old strengths, look no further than HandyLab. From biomedical research to the engineering and manufacturing of its cutting edge technologies, this growing Ann Arbor company represents the next and best evolution for Michigan's economy. 

Our Partners

30044
30045
30046
30047
30049
Washtenaw ISD logo
Eastern Michigan University
Ann Arbor Art Center
UMS
U of M Arts Initiative
Engage EMU

Common Ground Is Brewing

Support local stories and receive our signature roast straight to your door when you join at the Standard level (or above).

Drink Better, Read Local

Close the CTA

Don't miss out!

Everything Ann Arbor and Ypsilanti, in your inbox every week.

Close the CTA

Already a subscriber? Enter your email to hide this popup in the future.